As the largest resource of information specific to women's brain health, we are sure you will find what you are looking for, and promise that you will discover new information.
Published on: April 22, 2019
by Bob Yirka for Medical XPress:
A large team of researchers affiliated with a host of institutions across South Korea has developed a possible blood test to detect the early stages of Alzheimer’s disease in patients who have yet to exhibit symptoms. In their paper published in the journal Science Advances, the group describes their research and the technique they developed for detecting the disorder.
Alzheimer’s disease is, of course, a progressive disorder that involves neuronal deterioration in the brain, leading to a variety of symptoms, most notably memory loss. It is not curable and those afflicted eventually die.
Scientists have been studying Alzheimer’s disease for many years, and have learned that one of the things that happens in the brains of such patients is the buildup of an amyloid-beta (Aβ) peptide. While research into possible cures continues, a lot of effort is also being put into finding a test for the disorder before symptoms arise. Prior research has shown that Aβ is able to move from the brain into the bloodstream, suggesting that a blood test might be developed as a way to test for the disorder. Unfortunately, that idea has not panned out, as there is no way to determine if Aβ levels in the blood actually show that Alzheimer’s disease has begun. In this new effort, the researchers believe they have found a way to alter Aβ found in blood samples to reveal the presence of Aβ.
The researchers found that if a small molecule known as EPPS was added to a solution holding Aβ concentrations, the molecule would force them apart. That led them to the idea of testing the broken samples from patients diagnosed with the disorder against control groups to see if there were differences.
The researchers report that their technique reliably distinguishes between diagnosed patients and those in a control group. They also showed that the technique could be used as a way to monitor the progression of the disorder. They report that they are already making plans to make their technique available to doctors in clinical practice.
Approximately two-thirds of those diagnosed with Alzheimer’s disease (AD) are women. However, research into sex and gender differences in AD is astonishingly limited. Because the greatest risk factor for dementia is age, the discrepancy between...
Researchers at The University of Chicago have demonstrated that the type of bacteria living in the gut can influence the development of Alzheimer’s disease symptoms in mice. The study, which will be published May 16 in the Journal...
It is common for women to experience cognitive difficulties, sometimes referred to as “brain fog,” as they go through the menopause transition. They might be forgetful, or have trouble concentrating or thinking clearly. In one...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.